1. Measurement of subclinical carotid atherosclerosis may help in predicting risk for stroke in patients with diabetes

   • David Della-Morte
   • Camillo Ricordi
   • Tatjana Rundek

   Editorial 10 February 2013 Pages: 337 - 339

2. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

   • Hutan Ashrafian
   • Leanne Harling
   • Thanos Athanasiou

   Review Article 08 May 2013 Pages: 341 - 353

   

3. Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma

   • Gerald C. Wallace IV
   • Yaenette N. Dixon-Mah
   • Arabinda Das

   Review Article 02 April 2013 Pages: 355 - 366

   

4. NeuroProtective effects of adenosine receptor agonist coadministration with ascorbic acid on CA1 hippocampus in a mouse model of ischemia reperfusion injury

   • M. Zamani
   • M. Soleimani
   • M. Katebi

   Original Paper 03 May 2013 Pages: 367 - 374

   

5. IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke

   • Sheetal Bodhankar
   • Yingxin Chen
   • Halina Offner

   Original Paper 03 May 2013 Pages: 375 - 386

   

6. Experimentally-induced Wernicke’s encephalopathy modifies crucial rat brain parameters: the importance of Na⁺,K⁺-ATPase and a potentially neuroprotective role for antioxidant supplementation

   • Apostolos Zarros
   • Charis Liapi
   • Stylianos Tsakiris

   Original Paper 12 March 2013 Pages: 387 - 396

   

7. The effects of induced type-I diabetes on developmental regulation of insulin & insulin like growth factor-1 (IGF-1) receptors in the cerebellum of rat neonates

   • Hossein Haghir
   • Abd-Al-Rahim Rezaee
   • Javad Hami

   Original Paper 10 February 2013 Pages: 397 - 410

   

8. Neuroprotective effects of Pouteria ramiflora (Mart.) Radlk (Sapotaceae) extract on the brains of rats with streptozotocin-induced diabetes

   • Alice Vieira da Costa
   • Luciana Karen Calábria
   • Foued Salmen Espindola

   Original Paper 07 March 2013 Pages: 411 - 419

   

9. Berberine chloride improved synaptic plasticity in STZ induced diabetic rats

   • Hamid Kalalian Moghaddam
   • Tourandokht Baluchnejadmojarad
   • Abdolaziz Ronaghi

   Original Paper 03 May 2013 Pages: 421 - 428

   

10. Methylglyoxal-induced cytotoxicity in neonatal rat brain: a role for oxidative stress and MAP kinases

    • Luana Heimfarth
    • Samanta Oliveira Loureiro
    • Regina Pessoa-Pureur

    Original Paper 02 February 2013 Pages: 429 - 438

    

11. Modulation of crucial adenosinetriphosphatase activities due to U-74389G administration in a porcine model of intracerebral hemorrhage

    • Alexios Bimpis
    • Apostolos Papalois
    • Charis Liapi

    Original Paper 24 January 2013 Pages: 439 - 446

    

12. Influence of BDNF polymorphisms on Wilson’s disease susceptibility and clinical course

    • Dagmara Mirowska-Guzel
    • Tomasz Litwin
    • Anna Czlonkowska

    Original Paper Open access 22 March 2013 Pages: 447 - 453

13. Diffusion Tensor Imaging (DTI) and its clinical correlates in drug naïve Wilson’s disease

    • Rakesh Jadav
    • Jitender Saini
    • Arun B. Taly

    Original Paper 01 May 2013 Pages: 455 - 462

    

14. Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study

    • Gang Zheng
    • Long Jiang Zhang
    • Guang Ming Lu

    Original Paper 07 April 2013 Pages: 463 - 471

    

15. Cognitive assessment of patients with minimal hepatic encephalopathy in Brazil

    • D. S. Torres
    • J. Abrantes
    • C. E. Brandão‐Mello

    Original Paper Open access 28 April 2013 Pages: 473 - 483

    

16. Abnormal baseline brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI

    • Xiao-Fei Lv
    • Min Ye
    • Chuan-Miao Xie

    Original Paper 09 July 2013 Pages: 485 - 492

    

17. Increased susceptibility of brain acetylcholinesterase activity to methylmalonate in young rats with renal failure

    • André C. Affonso
    • Daniele G. Machado
    • Gustavo C. Ferreira

    Original Paper 09 March 2013 Pages: 493 - 500

    

18. Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia

    • Alexandra I. Zugno
    • Ricardo Filipe Julião
    • João Quevedo

    Original Paper 19 June 2013 Pages: 501 - 508

    

19. Effects of a co-treatment with pyruvate and creatine on dendritic spines in rat hippocampus and posterodorsal medial amygdala in a phenylketonuria animal model

    • Eleonora Araújo dos Reis
    • Elenara Rieger
    • Clóvis Milton Duval Wannmacher

    Original Paper 22 February 2013 Pages: 509 - 517

    

20. Congenital MTHFR deficiency causing early-onset cerebral stroke in a case homozygous for MTHFR thermolabile variant

    • Seung Jin Kim
    • Beom Hee Lee
    • Han-Wook Yoo

    Short Communication 23 March 2013 Pages: 519 - 522